수술후 통증 관리 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for postoperative pain management. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global postoperative pain management market from 2025 to 2032.

Key Insights:

• Postoperative Pain Management Market Size (2025E): USD 45.13 Billion
• Projected Market Value (2032F): USD 65.22 Billion
• Global Market Growth Rate (CAGR 2025 to 2032): 5.4%

Postoperative Pain Management Market - Report Scope:

Postoperative pain management plays a crucial role in improving patient recovery and outcomes following surgical procedures. This market includes a wide range of products and therapies such as analgesics (opioids and non-opioids), regional anesthesia techniques, patient-controlled analgesia devices, and non-pharmacological interventions. The postoperative pain management market caters to hospitals, surgical centers, and outpatient care settings, providing solutions that aim to reduce pain intensity, minimize opioid use, and enhance patient comfort and satisfaction. Market growth is driven by increasing surgical procedures worldwide, rising awareness of effective pain management protocols, and innovations in drug delivery and pain monitoring technologies.

Market Growth Drivers:

The global postoperative pain management market is propelled by several key factors, including the rising volume of surgical procedures due to aging populations and growing prevalence of chronic diseases. Increasing awareness among healthcare providers about the importance of effective pain control and the risks associated with opioid overuse further fuel demand for alternative and multimodal pain management approaches. Technological advancements, such as novel drug formulations, extended-release analgesics, and smart patient-controlled analgesia devices, contribute to improving treatment efficacy and safety. Moreover, government initiatives and clinical guidelines promoting enhanced recovery after surgery (ERAS) protocols support market expansion.

Market Restraints:

Despite promising growth prospects, the postoperative pain management market faces challenges related to opioid addiction concerns, stringent regulatory requirements, and high costs associated with advanced pain management therapies. The risk of adverse effects and complications linked to certain analgesics limits their widespread adoption. Additionally, inconsistent reimbursement policies and lack of standardized pain management protocols across regions pose barriers to market penetration, especially in developing economies.

Market Opportunities:

The postoperative pain management market presents significant growth opportunities driven by increasing investments in research and development, rising adoption of non-opioid analgesics, and expanding use of regional anesthesia techniques. Emerging markets with growing healthcare infrastructure and surgical care access offer untapped potential. Integration of digital health tools for pain monitoring and personalized pain management strategies can further enhance patient outcomes and market growth. Strategic collaborations between pharmaceutical companies, medical device manufacturers, and healthcare providers are essential to develop innovative, cost-effective, and patient-centric pain management solutions.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the postoperative pain management market globally?
• Which types of analgesics and pain management techniques are gaining prominence across various healthcare settings?
• How are technological advancements influencing treatment protocols and patient outcomes in postoperative pain management?
• Who are the key players contributing to the postoperative pain management market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global postoperative pain management market?

Competitive Intelligence and Business Strategy:

These companies invest in developing advanced analgesic formulations, non-opioid alternatives, and smart drug delivery systems tailored to diverse patient needs. Collaborations with healthcare providers and research institutions facilitate clinical validation and market access. Emphasis on patient education, safety, and evidence-based protocols fosters market growth and enhances patient outcomes in the evolving postoperative pain management landscape.

Key Companies Profiled:

• Teva Pharmaceutical Industries Ltd
• Novartis AG
• Allergan plc
• GlaxoSmithKline plc
• Mylan N.V.
• Johnson & Johnson
• Pfizer Inc.
• Purdue Pharma L.P
• Janssen Pharmaceuticals, Inc
• Endo International plc
• Baxter International
• Pacira Pharmaceuticals Inc.
• Cadila Healthcare Limited
• Cipla Limited
• Eisan
• LG Chem
• AbbVie Inc.
• Amgen Inc.
• Sun Pharmaceutical Ltd.

Postoperative Pain Management Market Research Segmentation:

The postoperative pain management market encompasses a diverse range of products, technologies, applications, and end-user segments, addressing various surgical procedures and patient populations.

By Drug

• Opioids
• Tramadol
• Oxycodone
• Hydrocodone
• Other Opioids
• NSAIDs
• Local Anesthetics
• Acetaminophen

By Route of Administration

• Injectable
• Oral
• Rectal
• Topical
• Transdermal
• Others

By Prescription Type

• Over-the-counter (OTC) Products
• Prescription Drugs

By Distribution Channel

• Hospital Pharmacies
• Specialty Clinics
• Long Term Care Centers
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Postoperative Pain Management Market Snapshot, 2025 and 2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Regulatory Landscape
• 3.2. Product Adoption Analysis
• 3.3. Value Chain Analysis
• 3.4. Key Deals and Mergers
• 3.5. PESTLE Analysis
• 3.6. Porter's Five Force Analysis

4. Global Postoperative Pain Management Market Outlook

• 4.1. Key Highlights
  • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
  • 4.1.2. Absolute $ Opportunity
• 4.2. Market Size (US$ Bn) Analysis and Forecast
  • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
  • 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
• 4.3. Global Postoperative Pain Management Market Outlook: Drug
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Drug, 2019-2024
  • 4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
    • 4.3.3.1. Opioids
      • 4.3.3.1.1. Tramadol
      • 4.3.3.1.2. Oxycodone
      • 4.3.3.1.3. Hydrocodone
      • 4.3.3.1.4. Other Opioids
    • 4.3.3.2. NSAIDs
    • 4.3.3.3. Local Anesthetics
    • 4.3.3.4. Acetaminophen
  • 4.3.4. Market Attractiveness Analysis: Drug
• 4.4. Global Postoperative Pain Management Market Outlook: Route of Administration
  • 4.4.1. Introduction / Key Findings
  • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Route of Administration, 2019-2024
  • 4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 4.4.3.1. Injectable
    • 4.4.3.2. Oral
    • 4.4.3.3. Rectal
    • 4.4.3.4. Topical
    • 4.4.3.5. Transdermal
    • 4.4.3.6. Others
  • 4.4.4. Market Attractiveness Analysis: Route of Administration
• 4.5. Global Postoperative Pain Management Market Outlook: Prescription Type
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Bn) Analysis, By Prescription Type, 2019-2024
  • 4.5.3. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
    • 4.5.3.1. Over-The-Counter (OTC) Products
    • 4.5.3.2. Prescription Drugs
  • 4.5.4. Market Attractiveness Analysis: Prescription Type
• 4.6. Global Postoperative Pain Management Market Outlook: Distribution Channel
  • 4.6.1. Introduction / Key Findings
  • 4.6.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2024
  • 4.6.3. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
    • 4.6.3.1. Hospital Pharmacies
    • 4.6.3.2. Specialty Clinics
    • 4.6.3.3. Long Term Care Centers
    • 4.6.3.4. Retail Pharmacies
    • 4.6.3.5. Drug Stores
    • 4.6.3.6. Online Pharmacies
  • 4.6.4. Market Attractiveness Analysis: Distribution Channel

5. Global Postoperative Pain Management Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
• 5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America Postoperative Pain Management Market Outlook

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 6.2.1. By Country
  • 6.2.2. By Drug
  • 6.2.3. By Route of Administration
  • 6.2.4. By Prescription Type
  • 6.2.5. By Distribution Channel
• 6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
  • 6.4.1. Opioids
    • 6.4.1.1. Tramadol
    • 6.4.1.2. Oxycodone
    • 6.4.1.3. Hydrocodone
    • 6.4.1.4. Other Opioids
  • 6.4.2. NSAIDs
  • 6.4.3. Local Anesthetics
  • 6.4.4. Acetaminophen
• 6.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
  • 6.5.1. Injectable
  • 6.5.2. Oral
  • 6.5.3. Rectal
  • 6.5.4. Topical
  • 6.5.5. Transdermal
  • 6.5.6. Others
• 6.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
  • 6.6.1. Over-The-Counter (OTC) Products
  • 6.6.2. Prescription Drugs
• 6.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
  • 6.7.1. Hospital Pharmacies
  • 6.7.2. Specialty Clinics
  • 6.7.3. Long Term Care Centers
  • 6.7.4. Retail Pharmacies
  • 6.7.5. Drug Stores
  • 6.7.6. Online Pharmacies
• 6.8. Market Attractiveness Analysis

7. Europe Postoperative Pain Management Market Outlook

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Drug
  • 7.2.3. By Route of Administration
  • 7.2.4. By Prescription Type
  • 7.2.5. By Distribution Channel
• 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Russia
  • 7.3.7. Rest of Europe
• 7.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
  • 7.4.1. Opioids
    • 7.4.1.1. Tramadol
    • 7.4.1.2. Oxycodone
    • 7.4.1.3. Hydrocodone
    • 7.4.1.4. Other Opioids
  • 7.4.2. NSAIDs
  • 7.4.3. Local Anesthetics
  • 7.4.4. Acetaminophen
• 7.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
  • 7.5.1. Injectable
  • 7.5.2. Oral
  • 7.5.3. Rectal
  • 7.5.4. Topical
  • 7.5.5. Transdermal
  • 7.5.6. Others
• 7.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
  • 7.6.1. Over-The-Counter (OTC) Products
  • 7.6.2. Prescription Drugs
• 7.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
  • 7.7.1. Hospital Pharmacies
  • 7.7.2. Specialty Clinics
  • 7.7.3. Long Term Care Centers
  • 7.7.4. Retail Pharmacies
  • 7.7.5. Drug Stores
  • 7.7.6. Online Pharmacies
• 7.8. Market Attractiveness Analysis

8. East Asia Postoperative Pain Management Market Outlook

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Drug
  • 8.2.3. By Route of Administration
  • 8.2.4. By Prescription Type
  • 8.2.5. By Distribution Channel
• 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
• 8.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
  • 8.4.1. Opioids
    • 8.4.1.1. Tramadol
    • 8.4.1.2. Oxycodone
    • 8.4.1.3. Hydrocodone
    • 8.4.1.4. Other Opioids
  • 8.4.2. NSAIDs
  • 8.4.3. Local Anesthetics
  • 8.4.4. Acetaminophen
• 8.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
  • 8.5.1. Injectable
  • 8.5.2. Oral
  • 8.5.3. Rectal
  • 8.5.4. Topical
  • 8.5.5. Transdermal
  • 8.5.6. Others
• 8.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
  • 8.6.1. Over-The-Counter (OTC) Products
  • 8.6.2. Prescription Drugs
• 8.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
  • 8.7.1. Hospital Pharmacies
  • 8.7.2. Specialty Clinics
  • 8.7.3. Long Term Care Centers
  • 8.7.4. Retail Pharmacies
  • 8.7.5. Drug Stores
  • 8.7.6. Online Pharmacies
• 8.8. Market Attractiveness Analysis

9. South Asia & Oceania Postoperative Pain Management Market Outlook

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Drug
  • 9.2.3. By Route of Administration
  • 9.2.4. By Prescription Type
  • 9.2.5. By Distribution Channel
• 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. India
  • 9.3.2. Southeast Asia
  • 9.3.3. ANZ
  • 9.3.4. Rest of South Asia & Oceania
• 9.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
  • 9.4.1. Opioids
    • 9.4.1.1. Tramadol
    • 9.4.1.2. Oxycodone
    • 9.4.1.3. Hydrocodone
    • 9.4.1.4. Other Opioids
  • 9.4.2. NSAIDs
  • 9.4.3. Local Anesthetics
  • 9.4.4. Acetaminophen
• 9.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
  • 9.5.1. Injectable
  • 9.5.2. Oral
  • 9.5.3. Rectal
  • 9.5.4. Topical
  • 9.5.5. Transdermal
  • 9.5.6. Others
• 9.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
  • 9.6.1. Over-The-Counter (OTC) Products
  • 9.6.2. Prescription Drugs
• 9.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
  • 9.7.1. Hospital Pharmacies
  • 9.7.2. Specialty Clinics
  • 9.7.3. Long Term Care Centers
  • 9.7.4. Retail Pharmacies
  • 9.7.5. Drug Stores
  • 9.7.6. Online Pharmacies
• 9.8. Market Attractiveness Analysis

10. Latin America Postoperative Pain Management Market Outlook

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Drug
  • 10.2.3. By Route of Administration
  • 10.2.4. By Prescription Type
  • 10.2.5. By Distribution Channel
• 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. Brazil
  • 10.3.2. Mexico
  • 10.3.3. Rest of Latin America
• 10.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
  • 10.4.1. Opioids
    • 10.4.1.1. Tramadol
    • 10.4.1.2. Oxycodone
    • 10.4.1.3. Hydrocodone
    • 10.4.1.4. Other Opioids
  • 10.4.2. NSAIDs
  • 10.4.3. Local Anesthetics
  • 10.4.4. Acetaminophen
• 10.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
  • 10.5.1. Injectable
  • 10.5.2. Oral
  • 10.5.3. Rectal
  • 10.5.4. Topical
  • 10.5.5. Transdermal
  • 10.5.6. Others
• 10.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
  • 10.6.1. Over-The-Counter (OTC) Products
  • 10.6.2. Prescription Drugs
• 10.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
  • 10.7.1. Hospital Pharmacies
  • 10.7.2. Specialty Clinics
  • 10.7.3. Long Term Care Centers
  • 10.7.4. Retail Pharmacies
  • 10.7.5. Drug Stores
  • 10.7.6. Online Pharmacies
• 10.8. Market Attractiveness Analysis

11. Middle East & Africa Postoperative Pain Management Market Outlook

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Drug
  • 11.2.3. By Route of Administration
  • 11.2.4. By Prescription Type
  • 11.2.5. By Distribution Channel
• 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. GCC Countries
  • 11.3.2. Egypt
  • 11.3.3. South Africa
  • 11.3.4. Northern Africa
  • 11.3.5. Rest of Middle East & Africa
• 11.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
  • 11.4.1. Opioids
    • 11.4.1.1. Tramadol
    • 11.4.1.2. Oxycodone
    • 11.4.1.3. Hydrocodone
    • 11.4.1.4. Other Opioids
  • 11.4.2. NSAIDs
  • 11.4.3. Local Anesthetics
  • 11.4.4. Acetaminophen
• 11.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
  • 11.5.1. Injectable
  • 11.5.2. Oral
  • 11.5.3. Rectal
  • 11.5.4. Topical
  • 11.5.5. Transdermal
  • 11.5.6. Others
• 11.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
  • 11.6.1. Over-The-Counter (OTC) Products
  • 11.6.2. Prescription Drugs
• 11.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
  • 11.7.1. Hospital Pharmacies
  • 11.7.2. Specialty Clinics
  • 11.7.3. Long Term Care Centers
  • 11.7.4. Retail Pharmacies
  • 11.7.5. Drug Stores
  • 11.7.6. Online Pharmacies
• 11.8. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2025
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping By Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. Teva Pharmaceutical Industries Ltd
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Products
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. Novartis AG
  • 12.3.3. Allergan plc
  • 12.3.4. GlaxoSmithKline plc
  • 12.3.5. Mylan N.V.
  • 12.3.6. Johnson & Johnson
  • 12.3.7. Pfizer Inc.
  • 12.3.8. Purdue Pharma L.P
  • 12.3.9. Janssen Pharmaceuticals, Inc
  • 12.3.10. Endo International plc
  • 12.3.11. Baxter International
  • 12.3.12. Pacira Pharmaceuticals Inc.
  • 12.3.13. Cadila Healthcare Limited
  • 12.3.14. Cipla Limited
  • 12.3.15. Eisan
  • 12.3.16. LG Chem
  • 12.3.17. AbbVie Inc.
  • 12.3.18. Amgen Inc.
  • 12.3.19. Sun Pharmaceutical Ltd.

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations